Table IV.
Status of the immunohistochemical staining profiling of the confirmed proteins, CD10, desmin and β-catenin in patients with ESS.
Proteins | Endometrial stromal nodules | Low-grade ESS | Undifferentiated endometrial sarcomas | Cellular leiomyomata |
---|---|---|---|---|
CD10 | 2+ | 1+ | 0 to 1+ | 0 |
Desmin | 0 to 1+ | 0 to 1+ | 0 to 1+ | 2+ |
β-catenin | 2+ | 2+ | 1+ | 0 |
The expression of each protein was investigated by immunohistochemical staining. Due to the low incidence of endometrial stromal sarcoma (ESS), a combination of staining profiling data was obtained from several studies.